Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Galiximab increases the antitumor efficacy of rituximab in follicular lymphoma

June 20, 2005

Avantogen receives milestone payment from Endocyte

June 20, 2005

Kuhnil expands development of nimotuzumab to Korea

June 17, 2005

FDA agrees to rolling NDA for Virulizin

June 15, 2005

Phase I study for Tarvacin in refractory advanced solid tumors

June 15, 2005

Actemra, world's first drug for Castleman's disease launched in Japan

June 13, 2005

Protox receives funding to develop lung cancer drug

June 10, 2005

Virulizin granted orphan drug status in Europe

June 9, 2005

European orphan drug designation for Oncophage in renal cell carcinoma

June 9, 2005

Phase II trial for FavId in Europe

June 9, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...